Joachim Eeckhout, Author at Labiotech.eu

About

Founder & Managing Director at Labiotech.eu. While I was studying biotechnology in Paris, I got frustrated by the lack of digital media available for the industry and decided to fix it! I launched Labiotech.eu in 2014 and grew it to the largest community for biotech professionals in Europe! Other than biotech news, I’m also a heavy reader of Sci-Fi and Fantasy.

Articles by Joachim Eeckhout

Neovacs lupus erythmatosis kinoid cytokine world day biotech therapy

News and Trends 10 May 2016

Today is World Lupus Day! Meet the people who are fighting this Rare disease

World Lupus Day is an initiative to increase the awareness around this disease which affects more than 5 million people worldwide. Last week in Paris, the biotech company Neovacs, which develops an innovative therapy against lupus, had gathered researchers, entrepreneurs and patients’ associations who are fighting the disease. I was there to meet them and […]

May 10, 2016 - 6 minutesmins - By Joachim Eeckhout

News and Trends 6 May 2016

Biotech of the Week: Affibody and its Super antibodies from Scandinavia

From North Israel, we once again depart North towards Scandinavia to visit Sweden. On one of the several islands that make Stockholm a very particular and special European capital, our Biotech of the week Affibody has its headquarters. City: Stockholm (Sweden) – (actually just down the road from the Karolinska Institute) Founded: 1998 Employees: 22 (as of 11/2015) […]

May 6, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 6 May 2016

Interview with Two Key People of the Fight Against Lupus

I was in Paris this week in the building of the Rare Disease Alliance, an association helping patients affected by a rare disease. The association lend their space to Neovacs, a biotech company from Paris, which was organising a gathering of experts of lupus. Lupus is one of the most common rare disease and affects more than 5 million […]

May 6, 2016 - 1 minutemin - By Joachim Eeckhout

News and Trends 22 Apr 2016

Biotech of the Week: Covagen, binding proteins to antibodies for Immunotherapy

We say our goodbyes to Belgium this week and head one more time to Switzerland. In Zürich, where you can find almost any kind of cheese, delicious chocolate and a beautiful view of the Swiss Alps near the city lake, is also where Covagen, our Biotech of the Week is located. City: Zürich (Switzerland) Founded: 2007 Employees: 23 (as of […]

April 22, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 15 Apr 2016

Biotech of the Week: ThromboGenics & Therapies against Eye Disease

This week, we say Auf wiedersehen to Vienna and move on to the North west. Leuven, the capital city of the Flemish Brabant province in Belgium, fairly close to the country’s capital Brussels. And it is also where ThromboGenics, our Biotech of The Week is located. City: Leuven (Belgium) Founded: 1998 Employees: 85 (including US) Market cap: […]

April 15, 2016 - 2 minutesmins - By Joachim Eeckhout

innovators bioupper biotech evarplanning panoxyvir wrap italy startuP biotech accelerator bioupper

News and Trends 12 Apr 2016

What sort of Biotech Startups are coming out of Italy at the moment?

BioUpper in Milan has launched the first acceleration platform for new entrepreneurs in the field of biotech and Medicine. Here are 3 of the winners awarded €50,000 each in funding. The project is funded by Novartis and Fondazione Cariplo – the Italian cultural and Scientific grant foundation now worth over €8Bn. The aim of the project is to enhance promising projects and finance […]

April 12, 2016 - 4 minutesmins - By Joachim Eeckhout

News and Trends 8 Apr 2016

Biotech of the Week: Activartis Immuno-Oncology in Vienna

This week, we leave Milan and head once again towards the East. Vienna: Austria’s palatial and stunning capital city is our destination, and is also where our Biotech of the week, Activartis, is located. City: Vienna (Austria) Founded: 2003 Employees: 11 – 50 (as of 12/2015) Financial Data: N/A CEO: Thomas Felzmann Mission: Currently in phase II clinical […]

April 8, 2016 - 1 minutemin - By Joachim Eeckhout

News and Trends 1 Apr 2016

Biotech of the Week: MolMed, Immuno-oncology made in ‘Milano’

From one fashion capital to the other, this week we leave Paris and head down to Milan. Home to some worldwide high-fashion brands, Da Vinci’s Last Supper mural and main city of the Lombardy region, Milan is also where MolMed, our Biotech of the Week, is based. City: Milan (Italy) Founded: 1996 Employees: (+/-) 120 (as of 12/2015) […]

April 1, 2016 - 1 minutemin - By Joachim Eeckhout

News and Trends 25 Mar 2016

Biotech of the Week: OSE Pharma, the ‘Significant’ Immunotherapy Player from Paris

This week, we head up full speed from Geneva with our eyes aiming towards Paris. Known for its beauty, bohemian lifestyle and, of course the Eiffel Tower, the Louvre and le baguette, Paris is also the home of OSE Pharma, our Biotech of the Week. City: Paris (France) Founded: 2012 Employees: N/A Financial Data: €24.3M total raised (as of […]

March 25, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 18 Mar 2016

Biotech of the Week: Addex Therapeutics, a Swiss Biotech on a Rollercoaster ride

This week we wave goodbye to the United Kingdom and all its glory and through the English channel, we head south to charming Switzerland. Geneva is our destination and it is where Addex Therapeutics, our Biotech of the Week, is based. City: Geneva (Switzerland) Founded: 2002 Employees: 5 Market Capitalization: €30M (3/2016) CEO: Tim Dyer Mission: Founded in […]

March 18, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 14 Mar 2016

5 Steps to Transform your Laboratory into an Automated Workspace!

Today’s laboratories work with a range of information sources – from samples, results, tests, storage, budget, client’s requests and so on. In this way, information finds itself at the heart of a lab, and is crucial for efficient research. Automation and digitalization of the workspace can therefore help labs to manage this large amount of information. Labiotech, in collaboration […]

March 14, 2016 - 7 minutesmins - By Joachim Eeckhout

News and Trends 11 Mar 2016

Biotech of the Week: Mission Therapeutics and a Cambridge Pathway against Cancer

From East to West, this week we say goodbye to Hungary and head up towards Queen Elizabeth II’s United Kingdom. Cambridge, known for its World renowned Academia is where Mission Therapeutics, our Biotech of the Week is located. City: Cambridge (UK) Founded: 2011 Employees: 30 Total raised: €110M (as of 02/2016) CEO: Anker Lundemose Mission: Founded in 2011, Mission Therapeutics, […]

March 11, 2016 - 1 minutemin - By Joachim Eeckhout

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us